Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
S-Ketamine by AFYX Therapeutics for Cluster Headache Syndrome (Cluster Headache): Likelihood of Approval
S-Ketamine is under clinical development by AFYX Therapeutics and currently in Phase II for Cluster Headache Syndrome (Cluster Headache). According...